Online Clinical Case Study (March 2008)
The
content of the Office Cardiology Series is provided by:
Dr. YIU Siu Fung
F.H.K.A.M. (Med), F.R.C.P. (Glasg), F.R.C.P. (Edin), Specialist
in Cardiology
Dr. LI Siu Lung, Steven
F.H.K.A.M. (Med), F.R.C.P. (Glasg), F.R.C.P. (Edin), F.R.C.P.
(Lond), Specialist in Cardiology
Dr. WONG Shou Pang, Alexander
F.R.C.P., F.H.K.A.M.(Med.), F.H.K.C.P., Specialist in Cardiology
臨床心臟科個案研究之內容誠蒙姚少峰醫生、李少隆醫生及王壽鵬醫生提供。
A 59-year-old, overweight gentleman presented with asymptomatic paroxysmal atrial fibrillation with a strongly positive treadmill. He underwent elective coronary angioplasty and stenting with the diagnosis of severe triple vessels disease 6 months ago. Echocardiogram at that time showed normal left ventricular systolic function. Left ventricular wall thickness was normal. The left atrium was mildly enlarged as a result of moderate functional mitral regurgitation.
His blood pressure was reported to be normal three months ago during a routine body checkup. He was diagnosed with mild to moderate hypertension at the time of coronary intervention. Combination therapy with an ACE inhibitor (perindopril 4 mg once daily) and a calcium channel blocker (felodipine 2.5 mg once daily) was initiated. Initially, his blood pressure was well controlled. Two weeks after initiation of the ACE inhibitor, his serum creatinine was 122 μmol/L and serum potassium was 4.8 mmol/L. However, it was noted that he was losing control over his blood pressure during subsequent followup visits. He developed intolerance to beta-blockers (bradycardia) and thiazide diuretics (acute gout) and his calcium channel blocker dosage escalated (dependent edema). His systolic blood pressure was brought under control to the 130 mmHg range with the maximum dosage of perindopril (acertil) at 8 mg once daily, felodipine (plendil) 2.5 mg once daily and carvedilol (dilatrend) 25 mg twice daily.
He felt dizzy after an acute episode of gastroenteritis. His blood pressure in the clinic was 95/ 60 mmHg with a weight loss of 2 kg. Blood tests for renal function revealed the following results — urea 17.3 mmol/L, creatinine 240 μmol/L and serum potassium 7.3 mmol/L. He was immediately admitted to the hospital for further management.
Answers
| 1. |
All
of the following are correct in the initial acute stage of management,
except: |
|
F. The underlying diagnosis is bilateral atherosclerotic renal artery stenoses. Clues to the diagnosis include new onset hypertension in this patient, with a background of severe coronary artery disease and refractory hypertension. The disease has two important clinical presentations: renovascular hypertension and ischemic nephropathy. Some patients may present with “flash” pulmonary edema with poorly controlled blood pressure despite normal left ventricular function and acute renal failure upon starting an ACE inhibitor. His presentation of acute renal impairment is multifactorial — dehydration (causing his acute weight loss) and relative hypotension after acute gastroenteritis leading to further renal ischemia. An ACE inhibitor will further aggravate the problem, since both kidneys distal to the high grade stenoses, require high levels of angiotensin II to maintain adequate perfusion. With an ACE inhibitor, renal perfusion in both kidneys is markedly diminished. Acute management of this patient is quite straightforward and is mainly targeted towards lowering his serum potassium, monitoring the cardiac rhythm, rehydration and cessation of all antihypertensive medications, particularly the ACE inhibitor, to prevent further renal ischemia. Obstructive uropathy remains an important differential diagnosis in patients with acute renal impairment, which can be easily ruled out by renal ultrasound. Bilateral renal artery stenoses may not produce asymmetric kidney size unless one renal artery is affected out of proportion to the other. MRA is a powerful way to screen for renal artery stenosis. However it should not be the first investigation to arrange in the acute phase, due to acute renal impairment. An acute renal failure can occur after exposure to gadolinium-based contrast agents in patients with moderate to severe chronic renal failure. There are recent reports in which exposure to gadolinium compounds has been linked to the development of nephrogenic systemic fibrosis in this patient population, which is a cause for concern. It is of great importance that radiologists be aware of this serious disease and exercise caution when considering the use of gadolinium-based contrast media in patients with moderate (glomerular filtration rate, <60 mL/min/1.73 m2) to severe (glomerular filtration rate, <15 mL/min/1.73 m2) renal disease. Therefore this test was only ordered after improvement of his renal function test. Bilateral renal artery stenting will be the treatment of choice in this patient. |
|
| Back to top |
A 34-year-old lady presented with asymptomatic white patches on her lower lip and oral cavity for about 2 months. There was no body rash. She recalled an episode of accidental biting of her lower lip a few months ago but its association with the appearance of the lip lesion could not be ascertained. She was a non-smoker and enjoyed good health, with no history of regular medication. On examination, there were a few patches of tiny, white, flat papules intermingled with white reticular striae on the bilateral buccal mucosae and gingival surface of the lips. There was no sign of inflammation on the lesions. A few shiny, white, flat-topped papules were found in confluence on the central part of the lower lip. No metallic dentition was found. Genital mucosa, nails and the skin of other parts of the body were spared. ANF was negative and liver function tests were normal. An incisional biopsy was done on the buccal lesion and confirmed the diagnosis.
| The
content of the Dermatology Series is provided by: Dr. MAK Kam Har, Dr. TANG Yuk Ming, William & Dr. CHAN Loi Yuen Specialists in Dermatology & Venereology 皮膚科病例研究之內容誠蒙麥錦霞醫生、鄧旭明醫生及陳來源醫生提供。 |
Answers